@article{d4452f6274894a03ba8311adef229779,
title = "Immediate impact of the COVID-19 pandemic on CTSA TL1 and KL2 training and career development",
abstract = "Clinical and Translational Science Award (CTSA) TL1 trainees and KL2 scholars were surveyed to determine the immediate impact of the COVID-19 pandemic on training and career development. The most negative impact was lack of access to research facilities, clinics, and human subjects, plus for KL2 scholars lack of access to team members and need for homeschooling. TL1 trainees reported having more time to think and write. Common strategies to maintain research productivity involved time management, virtual connections with colleagues, and shifting to research activities not requiring laboratory/clinic settings. Strategies for mitigating the impact of the COVID-19 pandemic on training and career development are described.",
keywords = "career development, COVID-19, KL2, research training, TL1",
author = "McCormack, \{Wayne T.\} and Bredella, \{Miriam A.\} and Ingbar, \{David H.\} and Jackson, \{Rebecca D.\} and Meagher, \{Emma A.\} and Morris, \{Cynthia D.\} and Nagel, \{Joan D.\} and Susan Pusek and Rubio, \{Doris M.\} and Kathryn Sandberg and Schnaper, \{H. William\} and Joel Tsevat and Umans, \{Jason G.\} and Scott McIntosh",
note = "Funding Information: Acknowledgments. This work was funded in part by the University of Rochester Center for Leading Innovation and Collaboration (CLIC), the CTSA coordinating center funded by NCATS (U24TR002260). From CLIC, the authors wish to thank Jacqueline Attia, Kathryn Buettner, Karen Grabowski, Laura Hassinger, and Rebecca Laird for assistance with survey design, implementation, and data management, and Manpreet Kaur and Astghik Baghinyan for assistance with qualitative analysis. The authors also thank Margaret Wallace and Ethan Lennox for review of the manuscript, and other members of the Workforce Development Enterprise Committee for helpful discussions. This work was also supported in part by the NIH NCATS through Grant Award Numbers: TL1TR001428 and UL1TR001427 (McCormack); KL2TR002542 (Bredella); UL1TR002494 and KL2TR002492 (Ingbar); UL1TR002733 (Jackson); UL1TR001878, TL1TR001880, and KL2TR001879 (Meagher); TL1TR002371 (Morris); UL1TR002489 (Pusek); KL2TR001856 (Rubio); TL1TR001431 (Sandberg); KL2TR001424 and UL1TR001423 (Schnaper); KL2TR002646 (Tsevat); KL2TR001432 and UL1TR001409 (Umans); and U24TR002260 (McIntosh). This work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NCATS, or CLIC. Funding Information: Clinical and translational research aims to move scientific discoveries to clinical innovations that diagnose, prevent, or treat disease. The Clinical and Translational Science Award (CTSA) program, funded by the National Center for Advancing Translational Sciences (NCATS), supports research training and mentored career awards at CTSA program institutions (hubs). By supporting predoctoral students and postdoctoral fellows through TL1 Awards and early stage investigators through KL2 Awards, NCATS endeavors to increase the number of well-trained clinical and translational scientists who will lead this research to improve human health [1]. Publisher Copyright: {\textcopyright} 2020 Cambridge University Press. All rights reserved.",
year = "2020",
doi = "10.1017/cts.2020.504",
language = "English (US)",
volume = "4",
pages = "556--561",
journal = "Journal of Clinical and Translational Science",
issn = "2059-8661",
publisher = "Cambridge University Press",
number = "6",
}